1. Home
  2. AKTX vs FAT Comparison

AKTX vs FAT Comparison

Compare AKTX & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • FAT
  • Stock Information
  • Founded
  • AKTX N/A
  • FAT 2017
  • Country
  • AKTX United States
  • FAT United States
  • Employees
  • AKTX N/A
  • FAT N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • AKTX Health Care
  • FAT Consumer Discretionary
  • Exchange
  • AKTX Nasdaq
  • FAT Nasdaq
  • Market Cap
  • AKTX 35.7M
  • FAT 32.2M
  • IPO Year
  • AKTX N/A
  • FAT 2017
  • Fundamental
  • Price
  • AKTX $0.76
  • FAT $1.92
  • Analyst Decision
  • AKTX Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • AKTX 2
  • FAT 1
  • Target Price
  • AKTX $3.30
  • FAT $10.00
  • AVG Volume (30 Days)
  • AKTX 91.6K
  • FAT 42.5K
  • Earning Date
  • AKTX 08-13-2025
  • FAT 10-29-2025
  • Dividend Yield
  • AKTX N/A
  • FAT 7.22%
  • EPS Growth
  • AKTX N/A
  • FAT N/A
  • EPS
  • AKTX N/A
  • FAT N/A
  • Revenue
  • AKTX N/A
  • FAT $577,500,000.00
  • Revenue This Year
  • AKTX N/A
  • FAT N/A
  • Revenue Next Year
  • AKTX N/A
  • FAT $7.74
  • P/E Ratio
  • AKTX N/A
  • FAT N/A
  • Revenue Growth
  • AKTX N/A
  • FAT 0.96
  • 52 Week Low
  • AKTX $0.57
  • FAT $1.75
  • 52 Week High
  • AKTX $3.85
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 37.47
  • FAT 47.51
  • Support Level
  • AKTX $0.75
  • FAT $1.83
  • Resistance Level
  • AKTX $0.89
  • FAT $1.99
  • Average True Range (ATR)
  • AKTX 0.07
  • FAT 0.07
  • MACD
  • AKTX 0.01
  • FAT 0.03
  • Stochastic Oscillator
  • AKTX 57.86
  • FAT 72.68

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: